Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 Sep 13;5(9):e12504. doi: 10.1371/journal.pone.0012504

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.

This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.

PMC Copyright notice

For each experimental treatment, the percent pupal or adult survival is normalized to that of the appropriate control, which has been set to 100%, and the relative delay to pupariation is normalized to that of the appropriate control, which has been set at 0. In this figure CS-A larval treatment groups are represented using circles and OR larval treatment groups by diamonds. The size of each data point is scaled to the inoculation dose (highest dose/largest circle is cfu/plate; smallest dose/smallest circle is cfu/plate; highest dose/largest diamond is ; lowest dose/smallest diamond is ); Pf0-1 (blue), SBW25 (green), Pf-5 (red), killed Pf-5 (gray) and a Pf-5 gacA mutant (open red circle). (A) The relative developmental delay (see Materials and Methods) during the larval stage (X-axis) was plotted against the percentage of larvae that survived to pupariate (Y-axis) for six different experiments. (B) The relative developmental delay during the pupal stage (X-axis) was plotted against the percentage of pupae that survived to adult survivors (Y-axis). (C) The relative developmental delay during larval and pupal stages (X-axis) was plotted against the percentage of larvae that survived to adult (Y-axis).

Inline graphic — For each experimental treatment, the percent pupal or adult survival is normalized to that of the appropriate control, which has been set to 100%, and the relative delay to pupariation is normalized to that of the appropriate control, which has been set at 0. In this figure CS-A larval treatment groups are represented using circles and OR larval treatment groups by diamonds. The size of each data point is scaled to the inoculation dose (highest dose/largest circle is cfu/plate; smallest dose/smallest circle is cfu/plate; highest dose/largest diamond is ; lowest dose/smallest diamond is ); Pf0-1 (blue), SBW25 (green), Pf-5 (red), killed Pf-5 (gray) and a Pf-5 gacA mutant (open red circle). (A) The relative developmental delay (see Materials and Methods) during the larval stage (X-axis) was plotted against the percentage of larvae that survived to pupariate (Y-axis) for six different experiments. (B) The relative developmental delay during the pupal stage (X-axis) was plotted against the percentage of pupae that survived to adult survivors (Y-axis). (C) The relative developmental delay during larval and pupal stages (X-axis) was plotted against the percentage of larvae that survived to adult (Y-axis).